🔎 Trials Near Me

Početna › Melanom › Ohio › Columbus

Kliničke studije za Melanom u gradu Columbus, OH

Jedna studija za Melanom traži sudionike na lokaciji u gradu Columbus ili blizu njega. Otvorite je da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • i još 8
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

U tijeku regrutacijaFaza 3
  • The Ohio State University Wexner Medical Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

U tijeku regrutacijaFaza 3
  • Ohio State University, Columbus
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

U tijeku regrutacijaFaza 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 75 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07068074

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

U tijeku regrutacijaFaza 1
  • Ohio State University, Columbus
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT06529822

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

U tijeku regrutacijaFaza 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • i još 15
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04511013

Project: Every Child for Younger Patients With Cancer

U tijeku regrutacijaOpažajna studija
  • Nationwide Children's Hospital, Columbus
  • Ohio State University Comprehensive Cancer Center, Columbus
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

U tijeku regrutacijaFaza 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05592626

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

U tijeku regrutacijaFaza 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 do 99 godina · Oba spola · Ažurirano 13. srp 2026. · NCT04697576

Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain

U tijeku regrutacijaFaza 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 11. lip 2026. · NCT05588453

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

U tijeku regrutacijaFaza 1/2
  • Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
Od 18 godina i više · Oba spola · Ažurirano 13. svi 2026. · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

U tijeku regrutacijaFaza 3
  • Ohio State Eye and Ear Institute, Columbus
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

U tijeku regrutacijaFaza 2/3
  • The Ohio State University, Columbus
Sve dobne skupine · Oba spola · Ažurirano 2. tra 2026. · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

U tijeku regrutacijaOpažajna studija
  • Memorial Hospital, Marysville · 27 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 17. ožu 2026. · NCT06418204

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

U tijeku regrutacijaFaza 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 do 99 godina · Oba spola · Ažurirano 10. ožu 2026. · NCT06223659

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • The Ohio State University Wexner Medical Center, Columbus
Sve dobne skupine · Oba spola · Ažurirano 9. ožu 2026. · NCT04792463

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

U tijeku regrutacijaFaza 3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 25. velj 2026. · NCT05549297

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Ohio State University Comprehensive Cancer Center, Columbus
Sve dobne skupine · Oba spola · Ažurirano 17. velj 2026. · NCT04567706

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

U tijeku regrutacijaFaza 3
  • Ohio State University Wexner Medical Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 17. pro 2025. · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

U tijeku regrutacijaOpažajna studija
  • Massive Bio SYNERGY-AI site, Columbus
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

U tijeku regrutacija
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 27. stu 2024. · NCT03860883

Studije za Melanom u drugim gradovima

Ostale studije u gradu Columbus

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.